Evidence map›Paper›PMID 28937624›Full record

ArticleMolecules (Basel, Switzerland)2017

Therapeutic Mechanisms of Vernonia amygdalina Delile in the Treatment of Prostate Cancer.

William Johnson, Paul B Tchounwou, Clement G Yedjou

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Effects of Dietary Inclusion ofVeterinary medicine international · 2026
    Article
  3. The ethyl acetate extract ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  4. International journal of inflammation · 2023
    Article
  5. Journal of biomedical research & environmental sciences · 2022
    Article
  6. Review
  7. Article
  8. International journal of molecular sciences · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Special Issue: Natural Products: Anticancer and Beyond.Molecules (Basel, Switzerland) · 2018
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

William JohnsonNatural Chemotherapeutics Research Laboratory, NIH-RCMI Center for Environmental Health College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P.O. Box 18540, Jackson, MS 39217, USA. willkjohnson@gmail.com.
Paul B TchounwouNatural Chemotherapeutics Research Laboratory, NIH-RCMI Center for Environmental Health College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P.O. Box 18540, Jackson, MS 39217, USA. paul.b.tchounwou@jsums.edu.
Clement G YedjouNatural Chemotherapeutics Research Laboratory, NIH-RCMI Center for Environmental Health College of Science, Engineering and Technology, Jackson State University, 1400 Lynch Street, P.O. Box 18540, Jackson, MS 39217, USA. clement.yedjou@jsums.edu.

Funding

RCMI-Center for Environmental HealthG12MD007581 · NIMHD · JACKSON STATE UNIVERSITY · PI TCHOUNWOU, PAUL B. · 2012 to 2017
$11.2M
NIMHD NIH HHS G12 MD007581
6 · The paper itself

Abstract

Prostate cancer patients have been suffering from limited treatment options due to late diagnosis, poor drug tolerance, and multi-drug resistance to almost all the current drug treatments. Therefore, it is important to seek a new alternative therapeutic medicine that can effectively prevent the disease and even eradicate the progression and metastasis of prostate cancer.

Indexed as

AntioxidantsApoptosisCell CycleCell Line, TumorCell ProliferationDNA DamageHumansLipid PeroxidationMaleMedicine, TraditionalOxidative StressPlant ExtractsPlant LeavesProstatic NeoplasmsVernoniaAntioxidantsPlant ExtractsapoptosisDNA damagenecrosisoxidative stressPC-3 cellsVernonia amygdalina Delile

Identifiers

PMID28937624
PMCPMC5661957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.